Jorge Nieva, MD

Title(s)Associate Professor of Clinical Medicine
SchoolKeck School of Medicine of Usc
AddressNOR 1441 Eastlake Ave. NTT Suite 3440
Off Campus
Los Angeles CA 90033-9173
Phone+1 323 865 0421
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    ASCO Award for Excellence in Clinical Trials
    National Cancer Institute Gold Certificate of Excellence
    Outstanding Teacher Award, Scripps Clinic
    Skaggs Scholar in Clinical Science
    Waltz Award for Leadership, Scripps Clinic
    Alpha Omega Alpha Medical Honors Society
    University of California, IrvineDepartment of Medicine Award
    Walter Blumeson Scholarship for Academic Promise
    Irving M. Reingold Prize in Pathology
    Irving M. Reingold Prize in Pathology
    American Association of Pathology Chairs Honor Society
    University of California, Irvine Excellence in Research
    University of California, IrvineDepartmental Honors, Biological Sciences

    Collapse Overview 
    Collapse Overview
    Dr. Jorge Nieva graduated from the University of California, Irvine College of Medicine in 1997, trained in internal medicine at University of California, San Diego and in oncology and hematology at the Scripps Clinic. In 2003 he joined the faculty of the Scripps Research Institute and the medical staff of the Scripps Clinic in La Jolla, CA. While at Scripps, Dr. Nieva pioneered new technology for the detection of cancer cells in the peripheral blood and discoveries related to the fundamental mechanisms of the immune system.

    Dr. Nieva was recruited to the Billings Clinic in Montana in 2007 where he served as department chair and was a program leader who established the multidisciplinary lung cancer and head/neck cancer clinics at the cancer center. While in Billings, Dr. Nieva led efforts to establish a research program in virus-delivered cancer gene therapy and immunotherapy. His teams were awarded certificates for excellence in the conduct of cancer clinical trials from the National Cancer Institute and the American Society of Clinical Oncology. Dr. Nieva returned to California, joining the faculty of the Keck School of Medicine in 2014.

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Required Scholarly Project Mentor

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Characterization of Thyroid Cancer among Hispanics in California, USA, from 2010 to 2020. Cancers (Basel). 2024 Mar 08; 16(6). Hsu RC, Tsai KY, Benjamin DJ, Chennapan K, Wojcik KY, Lee AW, Thomas JS, Nieva JJ, Liu L. PMID: 38539437.
      View in: PubMed   Mentions:
    2. Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11-Mutant Non-Small-Cell Lung Cancer. JCO Precis Oncol. 2024 Feb; 8:e2300371. Naqash AR, Floudas CS, Aber E, Maoz A, Nassar AH, Adib E, Choucair K, Xiu J, Baca Y, Ricciuti B, Alessi JV, Awad MM, Kim C, Judd J, Raez LE, Lopes G, Nieva JJ, Borghaei H, Takebe N, Ma PC, Halmos B, Kwiatkowski DJ, Liu SV, Mamdani H. PMID: 38330261; PMCID: PMC10860998.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Editorial: Equity in cancer care. Front Oncol. 2023; 13:1346785. Nieva JJ. PMID: 38250548; PMCID: PMC10797084.
      View in: PubMed   Mentions:
    4. Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical Trial. JAMA Oncol. 2023 Dec 01; 9(12):1669-1677. Takahashi N, Hao Z, Villaruz LC, Zhang J, Ruiz J, Petty WJ, Mamdani H, Riess JW, Nieva J, Pachecho JM, Fuld AD, Shum E, Chauhan A, Nichols S, Shimellis H, McGlone J, Sciuto L, Pinkiert D, Graham C, Shelat M, Kattappuram R, Abel M, Schroeder B, Upadhyay D, Krishnamurthy M, Sharma AK, Kumar R, Malin J, Schultz CW, Goyal S, Redon CE, Pommier Y, Aladjem MI, Gore SD, Steinberg SM, Vilimas R, Desai P, Thomas A. PMID: 37824137; PMCID: PMC10570917.
      View in: PubMed   Mentions: 2     Fields:    Translation:CTClinical Trials
    5. Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencing. BMC Cancer. 2023 Oct 18; 23(1):1000. Nagasaka M, Zhang SS, Baca Y, Xiu J, Nieva J, Vanderwalde A, Swensen JJ, Spetzler D, Korn WM, Raez LE, Liu SV, Ou SI. PMID: 37853341; PMCID: PMC10585918.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Complete response with pembrolizumab in recurrent squamous cell carcinoma of the oral tongue: A case report. Oral Oncol. 2023 Dec; 147:106597. Cheng JY, Hsu RC, Nieva JJ, Thomas JS. PMID: 37857230.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer. Front Oncol. 2023; 13:1215524. Hsu R, Chen D, Xia B, Feldman R, Cozen W, Raez LE, Borghaei H, Kim C, Nagasaka M, Mamdani H, Vanderwalde AM, Lopes G, Socinski MA, Wozniak AJ, Spira AI, Liu SV, Nieva JJ. PMID: 37700839; PMCID: PMC10494442.
      View in: PubMed   Mentions:
    8. Real world prognostic utility of platelet lymphocyte ratio and nutritional status in first-line immunotherapy response in stage IV non-small cell lung cancer. Cancer Treat Res Commun. 2023; 36:100752. MacDonald M, Poei D, Leyba A, Diep R, Chennapan K, Leon C, Xia B, Nieva JJ, Hsu R. PMID: 37611343.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    9. Implementation planning for equitable tobacco treatment services: a mixed methods assessment of contextual facilitators and barriers in a large comprehensive cancer center. Transl Behav Med. 2023 08 11; 13(8):539-550. Tsui J, Sloan K, Sheth R, Ewusi Boisvert E, Nieva J, Kim AW, Pang RD, Sussman S, Kirkpatrick M. PMID: 36940412; PMCID: PMC10848232.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subset. Transl Oncol. 2023 Oct; 36:101744. Nagasaka M, Brazel D, Baca Y, Xiu J, Al-Hallak MN, Kim C, Nieva J, Swensen JJ, Spetzler D, Korn WM, Socinski MA, Raez LE, Halmos B, Ou SI. PMID: 37516008; PMCID: PMC10410168.
      View in: PubMed   Mentions: 1  
    11. Response to Letter to the Editor Titled "Seize the Opportunity With Small Tissue Samples: The Tailor Teaches!" JTO Clin Res Rep. 2023 Jul; 4(7):100531. Chang CF, Diep R, MacDonald M, Rakocevic R, Nieva J. PMID: 37547097; PMCID: PMC10398580.
      View in: PubMed   Mentions:
    12. Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked. Clin Lung Cancer. 2023 11; 24(7):e242-e246. Bodor JN, Patel JD, Wakelee HA, Levy BP, Borghaei H, Pellini B, Costello MR, Dowell JE, Finley G, Huang CH, Neal JW, Nieva JJ, Puri S, Socinski MA, Thomas C, Ross EA, Litwin S, Clapper ML, Treat J. PMID: 37451930.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    13. Biopsy Method and Needle Size on Success of Next-Generation Sequencing in NSCLC: A Brief Report. JTO Clin Res Rep. 2023 Apr; 4(4):100497. Diep R, MacDonald M, Cooper R, Grzegorczyk A, Rakocevic R, Chang CF, Uy A, Cowgill N, Nieva JJ. PMID: 37090100; PMCID: PMC10119792.
      View in: PubMed   Mentions: 3  
    14. TRUST-II: a global phase II study of taletrectinib in ROS1-positive non-small-cell lung cancer and other solid tumors. Future Oncol. 2023 Jan; 19(2):123-135. Nagasaka M, Ohe Y, Zhou C, Choi CM, Yang N, Liu G, Felip E, Pérol M, Besse B, Nieva J, Raez L, Pennell NA, Dimou A, Marinis F, Ciardiello F, Seto T, Hu Z, Pan M, Wang W, Li S, Ou SI. PMID: 36877099.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    15. Understanding KRAS for better targeting. Transl Lung Cancer Res. 2023 Feb 28; 12(2):181-183. Patel R, Nieva J. PMID: 36895917; PMCID: PMC9989813.
      View in: PubMed   Mentions:
    16. A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non-Small Cell Lung Cancer. Clin Lung Cancer. 2023 05; 24(3):228-234. Iams WT, Balbach ML, Phillips S, Sacher A, Bestvina C, Velcheti V, Wang X, Marmarelis ME, Sethakorn N, Leal T, Sackstein PE, Kim C, Robinson MA, Mehta K, Hsu R, Nieva J, Patil T, Camidge DR. PMID: 36841727; PMCID: PMC10234144.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Characterization of mortality and high-risk characteristics of thyroid cancer in Filipinos using the California Cancer Registry. Front Public Health. 2022; 10:1104607. Hsu R, Tsai KY, Chennapan K, Wojcik KY, Lee AW, Nieva JJ, Liu L. PMID: 36743179; PMCID: PMC9893642.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center: Structure, Innovations, and Initial Outcomes. Cancer Control. 2023 Jan-Dec; 30:10732748231197878. Reams RR, Odedina FT, Carpten JD, Redda K, Stern MC, Krieger JL, Aparicio J, Hensel B, Askins N, Abreu A, Adams A, Agyare E, Ali J, Allen JM, Aló R, Baezconde-Garbanati L, Brant J, Brown CP, Buxbaum SG, Cohen P, Cozen W, Ezenwa MO, Falzarano S, Fillingim RB, Flores-Rozas H, Fredenburg KM, George T, Han B, Huang Y, Hughes Halbert C, Kiros GE, Lamango NS, Lee JH, Lyon DE, Mitchell DA, Mochona B, Nieva JJ, Offringa IA, Okunieff P, Parker A, Rhie SK, Richey JM, Rogers SC, Salhia B, Schmittgen TD, Segal R, Setiawan VW, Smith U, Su LM, Suther S, Trevino J, Velazquez-Villarreal EI, Webb FJ, Wu AH, Yao Y, Wilkie DJ. PMID: 37703814; PMCID: PMC10501072.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Multianalyte liquid biopsy to aid the diagnostic workup of breast cancer. NPJ Breast Cancer. 2022 Sep 27; 8(1):112. Setayesh SM, Hart O, Naghdloo A, Higa N, Nieva J, Lu J, Hwang S, Wilkinson K, Kidd M, Anderson A, Velasco CR, Kolatkar A, Matsumoto N, Nevarez R, Hicks JB, Mason J, Shishido SN, Kuhn P. PMID: 36167819; PMCID: PMC9515081.
      View in: PubMed   Mentions: 5  
    20. Evaluating Real World Mutational Differences Between Hispanics and Asians in NSCLC at a Large Academic Institution in Los Angeles. Clin Lung Cancer. 2022 Nov; 23(7):e443-e452. Hsu R, Herrmann A, Gaur K, Xia B, Nieva JJ. PMID: 35902325.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Retrospective Analysis of Real-World Management of EGFR-Mutated Advanced NSCLC, After First-Line EGFR-TKI Treatment: US Treatment Patterns, Attrition, and Survival Data. Drugs Real World Outcomes. 2022 Sep; 9(3):333-345. Nieva J, Reckamp KL, Potter D, Taylor A, Sun P. PMID: 35661118; PMCID: PMC9392819.
      View in: PubMed   Mentions: 3  
    22. Effect of sponsor on enrollment criteria in non-small cell lung cancer clinical trials. J Cancer Policy. 2022 09; 33:100336. Cooper RA, Chai Y, Nieva J. PMID: 35605888; PMCID: PMC10226152.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Characterization of Cellular and Acellular Analytes from Pre-Cystectomy Liquid Biopsies in Patients Newly Diagnosed with Primary Bladder Cancer. Cancers (Basel). 2022 Feb 01; 14(3). Shishido SN, Sayeed S, Courcoubetis G, Djaladat H, Miranda G, Pienta KJ, Nieva J, Hansel DE, Desai M, Gill IS, Kuhn P, Mason J. PMID: 35159025; PMCID: PMC8833768.
      View in: PubMed   Mentions: 8  
    24. Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas. Oncotarget. 2021 Dec 07; 12(25):2449-2458. Hsu R, Baca Y, Xiu J, Wang R, Bodor JN, Kim C, Khan H, Mamdani H, Nagasaka M, Puri S, Liu SV, Korn WM, Nieva JJ. PMID: 34917263; PMCID: PMC8664394.
      View in: PubMed   Mentions: 4     Fields:    
    25. Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer. Mol Cancer Ther. 2021 12; 20(12):2577-2584. Judd J, Abdel Karim N, Khan H, Naqash AR, Baca Y, Xiu J, VanderWalde AM, Mamdani H, Raez LE, Nagasaka M, Pai SG, Socinski MA, Nieva JJ, Kim C, Wozniak AJ, Ikpeazu C, de Lima Lopes G, Spira AI, Korn WM, Kim ES, Liu SV, Borghaei H. PMID: 34518295.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    26. NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types. Br J Cancer. 2022 02; 126(3):514-520. Rolfo C, Drilon A, Hong D, McCoach C, Dowlati A, Lin JJ, Russo A, Schram AM, Liu SV, Nieva JJ, Nguyen T, Eshaghian S, Morse M, Gettinger S, Mobayed M, Goldberg S, Araujo-Mino E, Vidula N, Bardia A, Subramanian J, Sashital D, Stinchcombe T, Kiedrowski L, Price K, Gandara DR. PMID: 34480094; PMCID: PMC8811064.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    27. Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC). Lung Cancer. 2021 10; 160:92-98. Nagasaka M, Asad MFB, Al Hallak MN, Uddin MH, Sukari A, Baca Y, Xiu J, Magee D, Mamdani H, Uprety D, Kim C, Xia B, Liu SV, Nieva JJ, Lopes G, Bepler G, Borghaei H, Demeure MJ, Raez LE, Ma PC, Puri S, Korn WM, Azmi AS. PMID: 34482103; PMCID: PMC8853639.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    28. Blood-Based Multi-Cancer Detection Using a Novel Variant Calling Assay (DEEPGENTM): Early Clinical Results. Cancers (Basel). 2021 Aug 15; 13(16). Ris F, Hellan M, Douissard J, Nieva JJ, Triponez F, Woo Y, Geller D, Buchs NC, Buehler L, Moenig S, Iselin CE, Karenovics W, Petignat P, Lam GT, Undurraga Malinervo M, Tuttle R, Ouellette J, Bose D, Ismail N, Toso C. PMID: 34439258; PMCID: PMC8392437.
      View in: PubMed   Mentions: 3  
    29. Clinical management of immune-related adverse events following immunotherapy treatment in patients with non-small cell lung cancer. J Investig Med. 2021 10; 69(7):1281-1286. Green HE, Nieva J. PMID: 34127515; PMCID: PMC8478790.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Effect of prior therapy on tumor mutational burden in NSCLC. Transl Lung Cancer Res. 2021 Mar; 10(3):1231-1238. Jonna S, Vanderwalde A, Nieva J, Poorman KA, Saul M, von Buttlar X, Hu JY, Liu SV. PMID: 33889505; PMCID: PMC8044473.
      View in: PubMed   Mentions: 2  
    31. Treatment response and tumor evolution: lessons from an extended series of multianalyte liquid biopsies in a metastatic breast cancer patient. Cold Spring Harb Mol Case Stud. 2020 12; 6(6). Welter L, Xu L, McKinley D, Dago AE, Prabakar RK, Restrepo-Vassalli S, Xu K, Rodriguez-Lee M, Kolatkar A, Nevarez R, Ruiz C, Nieva J, Kuhn P, Hicks J. PMID: 33203646; PMCID: PMC7784493.
      View in: PubMed   Mentions: 16     Fields:    Translation:Cells
    32. Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters. JCO Clin Cancer Inform. 2020 09; 4:839-853. Nilanon T, Nocera LP, Martin AS, Kolatkar A, May M, Hasnain Z, Ueno NT, Yennu S, Alexander A, Mejia AE, Boles RW, Li M, Lee JSH, Hanlon SE, Cozzens Philips FA, Quinn DI, Newton PK, Broderick J, Shahabi C, Kuhn P, Nieva JJ. PMID: 32970482; PMCID: PMC7531613.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    33. Quantified Kinematics to Evaluate Patient Chemotherapy Risks in Clinic. JCO Clin Cancer Inform. 2020 06; 4:583-601. Hasnain Z, Nilanon T, Li M, Mejia A, Kolatkar A, Nocera L, Shahabi C, Cozzens Philips FA, Lee JSH, Hanlon SE, Vaidya P, Ueno NT, Yennu S, Newton PK, Kuhn P, Nieva J. PMID: 32598179; PMCID: PMC7328110.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    34. A Systematic Review of the Efficacy of Preclinical Models of Lung Cancer Drugs. Front Oncol. 2020; 10:591. Pan E, Bogumil D, Cortessis V, Yu S, Nieva J. PMID: 32391273; PMCID: PMC7190806.
      View in: PubMed   Mentions: 12  
    35. Intravenous 5-fluoro-2'-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2020 05; 85(5):979-993. Coyne GO', Wang L, Zlott J, Juwara L, Covey JM, Beumer JH, Cristea MC, Newman EM, Koehler S, Nieva JJ, Garcia AA, Gandara DR, Miller B, Khin S, Miller SB, Steinberg SM, Rubinstein L, Parchment RE, Kinders RJ, Piekarz RL, Kummar S, Chen AP, Doroshow JH. PMID: 32314030; PMCID: PMC7188725.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    36. Preanalytical Variables for the Genomic Assessment of the Cellular and Acellular Fractions of the Liquid Biopsy in a Cohort of Breast Cancer Patients. J Mol Diagn. 2020 03; 22(3):319-337. Shishido SN, Welter L, Rodriguez-Lee M, Kolatkar A, Xu L, Ruiz C, Gerdtsson AS, Restrepo-Vassalli S, Carlsson A, Larsen J, Greenspan EJ, Hwang ES, Waitman KR, Nieva J, Bethel K, Hicks J, Kuhn P. PMID: 31978562; PMCID: PMC7103765.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    37. Single cell correlation analysis of liquid and solid biopsies in metastatic colorectal cancer. Oncotarget. 2019 Dec 17; 10(66):7016-7030. Gerdtsson AS, Thiele JA, Shishido SN, Zheng S, Schaffer R, Bethel K, Curley S, Lenz HJ, Hanna DL, Nieva J, Kolatkar A, Ruiz C, Rodriguez-Lee M, Oakley Iii GJ, Lee JSH, Hicks J, Kuhn P. PMID: 31903162; PMCID: PMC6925029.
      View in: PubMed   Mentions: 8     Fields:    
    38. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials. Lancet Oncol. 2020 02; 21(2):271-282. Doebele RC, Drilon A, Paz-Ares L, Siena S, Shaw AT, Farago AF, Blakely CM, Seto T, Cho BC, Tosi D, Besse B, Chawla SP, Bazhenova L, Krauss JC, Chae YK, Barve M, Garrido-Laguna I, Liu SV, Conkling P, John T, Fakih M, Sigal D, Loong HH, Buchschacher GL, Garrido P, Nieva J, Steuer C, Overbeck TR, Bowles DW, Fox E, Riehl T, Chow-Maneval E, Simmons B, Cui N, Johnson A, Eng S, Wilson TR, Demetri GD, trial investigators. PMID: 31838007; PMCID: PMC7461630.
      View in: PubMed   Mentions: 473     Fields:    Translation:Humans
    39. Mandatory Research Biopsy Requirements Delay Initiation of Clinical Trials. Front Oncol. 2019; 9:968. Cheng JH, Tiulim JW, Zhou S, El-Khoueiry A, Nieva J. PMID: 31681560; PMCID: PMC6813196.
      View in: PubMed   Mentions: 4  
    40. A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 Study. J Thorac Oncol. 2020 01; 15(1):110-119. Schenk EL, Mandrekar SJ, Dy GK, Aubry MC, Tan AD, Dakhil SR, Sachs BA, Nieva JJ, Bertino E, Lee Hann C, Schild SE, Wadsworth TW, Adjei AA, Molina JR. PMID: 31605793; PMCID: PMC7279615.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCellsCTClinical Trials
    41. Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer. J Transl Med. 2019 08 28; 17(1):294. Shishido SN, Carlsson A, Nieva J, Bethel K, Hicks JB, Bazhenova L, Kuhn P. PMID: 31462312; PMCID: PMC6714097.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    42. Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer. J Thorac Oncol. 2019 11; 14(11):1901-1911. Horn L, Whisenant JG, Wakelee H, Reckamp KL, Qiao H, Leal TA, Du L, Hernandez J, Huang V, Blumenschein GR, Waqar SN, Patel SP, Nieva J, Oxnard GR, Sanborn RE, Shaffer T, Garg K, Holzhausen A, Harrow K, Liang C, Lim LP, Li M, Lovly CM. PMID: 31446141; PMCID: PMC6823161.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCTClinical Trials
    43. Patient reported outcomes can improve performance status assessment: a pilot study. J Patient Rep Outcomes. 2019 Jul 16; 3(1):41. Broderick JE, May M, Schwartz JE, Li M, Mejia A, Nocera L, Kolatkar A, Ueno NT, Yennu S, Lee JSH, Hanlon SE, Cozzens Philips FA, Shahabi C, Kuhn P, Nieva J. PMID: 31313047; PMCID: PMC6635569.
      View in: PubMed   Mentions: 9  
    44. Trimodality vs Chemoradiation and Salvage Resection in cN2 Stage IIIA Non-Small Cell Lung Cancer. Semin Thorac Cardiovasc Surg. 2020; 32(1):153-159. Ye JC, Ding L, Atay SM, Nieva JJ, McFadden PM, Chang E, Kim AW. PMID: 31220530; PMCID: PMC7517707.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    45. Detection of NRG1 Gene Fusions in Solid Tumors. Clin Cancer Res. 2019 Aug 15; 25(16):4966-4972. Jonna S, Feldman RA, Swensen J, Gatalica Z, Korn WM, Borghaei H, Ma PC, Nieva JJ, Spira AI, Vanderwalde AM, Wozniak AJ, Kim ES, Liu SV. PMID: 30988082; PMCID: PMC7470623.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    46. Tuberculosis following PD-1 blockade for cancer immunotherapy. Sci Transl Med. 2019 01 16; 11(475). Barber DL, Sakai S, Kudchadkar RR, Fling SP, Day TA, Vergara JA, Ashkin D, Cheng JH, Lundgren LM, Raabe VN, Kraft CS, Nieva JJ, Cheever MA, Nghiem PT, Sharon E. PMID: 30651320; PMCID: PMC7372940.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansAnimalsCells
    47. Radiomics in Pulmonary Lesion Imaging. AJR Am J Roentgenol. 2019 03; 212(3):497-504. Hassani C, Varghese BA, Nieva J, Duddalwar V. PMID: 30620678.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    48. A new anion exchange purification method for Cu stable isotopes in blood samples. Anal Bioanal Chem. 2019 Jan; 411(3):765-776. Yang SC, Welter L, Kolatkar A, Nieva J, Waitman KR, Huang KF, Liao WH, Takano S, Berelson WM, West AJ, Kuhn P, John SG. PMID: 30467768; PMCID: PMC7450686.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    49. Low-dimensional dynamical characterization of human performance of cancer patients using motion data. Clin Biomech (Bristol, Avon). 2018 07; 56:61-69. Hasnain Z, Li M, Dorff T, Quinn D, Ueno NT, Yennu S, Kolatkar A, Shahabi C, Nocera L, Nieva J, Kuhn P, Newton PK. PMID: 29803824; PMCID: PMC7519623.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    50. When it comes to genomic analysis of tumours, don't buy in bulk. Br J Cancer. 2018 05; 118(10):1281-1282. Nieva J, Hicks J. PMID: 29743553; PMCID: PMC5959923.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    51. Effect of Blood Collection Tube Type and Time to Processing on the Enumeration and High-Content Characterization of Circulating Tumor Cells Using the High-Definition Single-Cell Assay. Arch Pathol Lab Med. 2018 Feb; 142(2):198-207. Rodríguez-Lee M, Kolatkar A, McCormick M, Dago AD, Kendall J, Carlsson NA, Bethel K, Greenspan EJ, Hwang SE, Waitman KR, Nieva JJ, Hicks J, Kuhn P. PMID: 29144792; PMCID: PMC7679174.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    52. Biophysical technologies for understanding circulating tumor cell biology and metastasis. Transl Lung Cancer Res. 2017 Aug; 6(4):473-485. Su DW, Nieva J. PMID: 28904890; PMCID: PMC5583073.
      View in: PubMed   Mentions: 7  
    53. Development of metastatic brain disease involves progression through lung metastases in EGFR mutated non-small cell lung cancer. Converg Sci Phys Oncol. 2017 Sep; 3(3). In G, Mason J, Lin S, Newton PK, Kuhn P, Nieva J. PMID: 30283700; PMCID: PMC6166474.
      View in: PubMed   Mentions: 3  
    54. Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival. Cancer Epidemiol Biomarkers Prev. 2017 07; 26(7):1139-1145. Boffa DJ, Graf RP, Salazar MC, Hoag J, Lu D, Krupa R, Louw J, Dugan L, Wang Y, Landers M, Suraneni M, Greene SB, Magaña M, Makani S, Bazhenova L, Dittamore RV, Nieva J. PMID: 28446544; PMCID: PMC5500408.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    55. A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer. Oncologist. 2016 10; 21(10):1163-1164. Chiappori AA, Otterson GA, Dowlati A, Traynor AM, Horn L, Owonikoko TK, Ross HJ, Hann CL, Abu Hejleh T, Nieva J, Zhao X, Schell M, Sullivan DM. PMID: 27694157; PMCID: PMC5061534.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    56. Spatiotemporal progression of metastatic breast cancer: a Markov chain model highlighting the role of early metastatic sites. NPJ Breast Cancer. 2015; 1:15018. Newton PK, Mason J, Venkatappa N, Jochelson MS, Hurt B, Nieva J, Comen E, Norton L, Kuhn P. PMID: 28721371; PMCID: PMC5515198.
      View in: PubMed   Mentions: 15  
    57. Oncolytic viruses: perspectives on clinical development. Curr Opin Virol. 2015 Aug; 13:55-60. Burke J, Nieva J, Borad MJ, Breitbach CJ. PMID: 25989094.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    58. A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma. Oral Oncol. 2015 Apr; 51(4):376-82. Gilbert J, Schell MJ, Zhao X, Murphy B, Tanvetyanon T, Leon ME, Neil Hayes D, Haigentz M, Saba N, Nieva J, Bishop J, Sidransky D, Ravi R, Bedi A, Chung CH. PMID: 25593015; PMCID: PMC4459134.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    59. Entropy, complexity, and Markov diagrams for random walk cancer models. Sci Rep. 2014 Dec 19; 4:7558. Newton PK, Mason J, Hurt B, Bethel K, Bazhenova L, Nieva J, Kuhn P. PMID: 25523357; PMCID: PMC4894412.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    60. Circulating tumor microemboli diagnostics for patients with non-small-cell lung cancer. J Thorac Oncol. 2014 Aug; 9(8):1111-9. Carlsson A, Nair VS, Luttgen MS, Keu KV, Horng G, Vasanawala M, Kolatkar A, Jamali M, Iagaru AH, Kuschner W, Loo BW, Shrager JB, Bethel K, Hoh CK, Bazhenova L, Nieva J, Kuhn P, Gambhir SS. PMID: 25157764; PMCID: PMC4145608.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    61. Adrenal metastases in lung cancer: clinical implications of a mathematical model. J Thorac Oncol. 2014 Apr; 9(4):442-6. Bazhenova L, Newton P, Mason J, Bethel K, Nieva J, Kuhn P. PMID: 24736064; PMCID: PMC3989547.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    62. An observational study of circulating tumor cells and (18)F-FDG PET uptake in patients with treatment-naive non-small cell lung cancer. PLoS One. 2013; 8(7):e67733. Nair VS, Keu KV, Luttgen MS, Kolatkar A, Vasanawala M, Kuschner W, Bethel K, Iagaru AH, Hoh C, Shrager JB, Loo BW, Bazhenova L, Nieva J, Gambhir SS, Kuhn P. PMID: 23861795; PMCID: PMC3702496.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    63. Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients. Cancer. 2013 Jul 01; 119(13):2383-90. Weickhardt AJ, Doebele RC, Purcell WT, Bunn PA, Oton AB, Rothman MS, Wierman ME, Mok T, Popat S, Bauman J, Nieva J, Novello S, Ou SH, Camidge DR. PMID: 23585220; PMCID: PMC3686910.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    64. Spreaders and sponges define metastasis in lung cancer: a Markov chain Monte Carlo mathematical model. Cancer Res. 2013 May 01; 73(9):2760-9. Newton PK, Mason J, Bethel K, Bazhenova L, Nieva J, Norton L, Kuhn P. PMID: 23447576; PMCID: PMC3644026.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    65. Fluid biopsy for solid tumors: a patient's companion for lifelong characterization of their disease. Future Oncol. 2012 Aug; 8(8):989-98. Nieva JJ, Kuhn P. PMID: 22894671; PMCID: PMC3658625.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    66. A pilot study of long-acting octreotide for symptomatic malignant ascites. Oncology. 2012; 82(6):315-20. Jatoi A, Nieva JJ, Qin R, Loprinzi CL, Wos EJ, Novotny PJ, Moore DF, Mowat RB, Bechar N, Pajon ER, Hartmann LC. PMID: 22572824; PMCID: PMC3559024.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    67. ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy. Lung Cancer. 2012 Aug; 77(2):421-6. Das M, Riess JW, Frankel P, Schwartz E, Bennis R, Hsieh HB, Liu X, Ly JC, Zhou L, Nieva JJ, Wakelee HA, Bruce RH. PMID: 22555222.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    68. A stochastic Markov chain model to describe lung cancer growth and metastasis. PLoS One. 2012; 7(4):e34637. Newton PK, Mason J, Bethel K, Bazhenova LA, Nieva J, Kuhn P. PMID: 22558094; PMCID: PMC3338733.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    69. Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors. Phys Biol. 2012 Feb; 9(1):016001. Cho EH, Wendel M, Luttgen M, Yoshioka C, Marrinucci D, Lazar D, Schram E, Nieva J, Bazhenova L, Morgan A, Ko AH, Korn WM, Kolatkar A, Bethel K, Kuhn P. PMID: 22306705; PMCID: PMC3387999.
      View in: PubMed   Mentions: 111     Fields:    Translation:HumansCells
    70. High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysis. Phys Biol. 2012 Feb; 9(1):016004. Nieva J, Wendel M, Luttgen MS, Marrinucci D, Bazhenova L, Kolatkar A, Santala R, Whittenberger B, Burke J, Torrey M, Bethel K, Kuhn P. PMID: 22306961; PMCID: PMC3388002.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCellsCTClinical Trials
    71. Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers. Phys Biol. 2012 Feb; 9(1):016003. Marrinucci D, Bethel K, Kolatkar A, Luttgen MS, Malchiodi M, Baehring F, Voigt K, Lazar D, Nieva J, Bazhenova L, Ko AH, Korn WM, Schram E, Coward M, Yang X, Metzner T, Lamy R, Honnatti M, Yoshioka C, Kunken J, Petrova Y, Sok D, Nelson D, Kuhn P. PMID: 22306768; PMCID: PMC3387996.
      View in: PubMed   Mentions: 147     Fields:    Translation:HumansCells
    72. Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology. Phys Biol. 2012 Feb; 9(1):016005. Wendel M, Bazhenova L, Boshuizen R, Kolatkar A, Honnatti M, Cho EH, Marrinucci D, Sandhu A, Perricone A, Thistlethwaite P, Bethel K, Nieva J, Heuvel Mv, Kuhn P. PMID: 22307026; PMCID: PMC3387995.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCellsCTClinical Trials
    73. Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans. Nature. 2011 Aug 31; 477(7362):99-102. Breitbach CJ, Burke J, Jonker D, Stephenson J, Haas AR, Chow LQ, Nieva J, Hwang TH, Moon A, Patt R, Pelusio A, Le Boeuf F, Burns J, Evgin L, De Silva N, Cvancic S, Robertson T, Je JE, Lee YS, Parato K, Diallo JS, Fenster A, Daneshmand M, Bell JC, Kirn DH. PMID: 21886163.
      View in: PubMed   Mentions: 265     Fields:    Translation:HumansCellsCTClinical Trials
    74. Cholesterol secosterol aldehydes induce amyloidogenesis and dysfunction of wild-type tumor protein p53. Chem Biol. 2011 Jul 29; 18(7):920-7. Nieva J, Song BD, Rogel JK, Kujawara D, Altobel L, Izharrudin A, Boldt GE, Grover RK, Wentworth AD, Wentworth P. PMID: 21802012; PMCID: PMC3148486.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    75. Cytomorphology of circulating colorectal tumor cells:a small case series. J Oncol. 2010; 2010:861341. Marrinucci D, Bethel K, Lazar D, Fisher J, Huynh E, Clark P, Bruce R, Nieva J, Kuhn P. PMID: 20111743; PMCID: PMC2810476.
      View in: PubMed   Mentions: 60  
    76. Circulating tumor cells from well-differentiated lung adenocarcinoma retain cytomorphologic features of primary tumor type. Arch Pathol Lab Med. 2009 Sep; 133(9):1468-71. Marrinucci D, Bethel K, Luttgen M, Bruce RH, Nieva J, Kuhn P. PMID: 19722757; PMCID: PMC4422331.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    77. The ratio of cholesterol 5,6-secosterols formed from ozone and singlet oxygen offers insight into the oxidation of cholesterol in vivo. Chem Commun (Camb). 2009 Jun 07; (21):3098-100. Wentworth AD, Song BD, Nieva J, Shafton A, Tripurenani S, Wentworth P. PMID: 19462099; PMCID: PMC2819220.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    78. Purification and characterization of sideroblasts from patients with acquired and hereditary sideroblastic anaemia. Br J Haematol. 2008 Nov; 143(3):446-50. Martin FM, Prchal J, Nieva J, Saven A, Andrey J, Bethel K, Barton JC, Aripally G, Bottomley SS, Friedman JS. PMID: 18729851; PMCID: PMC2603068.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    79. Lipid-derived aldehydes accelerate light chain amyloid and amorphous aggregation. Biochemistry. 2008 Jul 22; 47(29):7695-705. Nieva J, Shafton A, Altobell LJ, Tripuraneni S, Rogel JK, Wentworth AD, Lerner RA, Wentworth P. PMID: 18578541.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    80. Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. Thromb Res. 2008; 122(5):604-9. Tilley RE, Holscher T, Belani R, Nieva J, Mackman N. PMID: 18262600; PMCID: PMC2572216.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    81. Understanding hairy cell leukemia genetics. Leuk Lymphoma. 2007 Apr; 48(4):653-4. Nieva J, Saven A. PMID: 17454620.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    82. The clinical significance of circulating tissue factor in prostate cancer. Thromb Haemost. 2007 Mar; 97(3):329-30. Nieva J. PMID: 17334495.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    83. Case study of the morphologic variation of circulating tumor cells. Hum Pathol. 2007 Mar; 38(3):514-9. Marrinucci D, Bethel K, Bruce RH, Curry DN, Hsieh B, Humphrey M, Krivacic RT, Kroener J, Kroener L, Ladanyi A, Lazarus NH, Nieva J, Kuhn P. PMID: 17188328.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCells
    84. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med. 2006 Oct 19; 355(16):1672-81. Bussel JB, Kuter DJ, George JN, McMillan R, Aledort LM, Conklin GT, Lichtin AE, Lyons RM, Nieva J, Wasser JS, Wiznitzer I, Kelly R, Chen CF, Nichol JL. PMID: 17050891.
      View in: PubMed   Mentions: 121     Fields:    Translation:HumansCTClinical Trials
    85. Use of optophoresis as an in vitro predictor of cell response to chemotherapy for chronic lymphocytic leukemia. Leuk Lymphoma. 2006 Oct; 47(10):2194-202. Nerenberg M, Kariv I, McNeeley P, Marchand P, Sur S, Diver J, Riccitelli S, Nieva J, Saven A. PMID: 17071495.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    86. Proatherogenic effects of the cholesterol ozonolysis products, atheronal-A and atheronal-B. Biochemistry. 2006 Jun 13; 45(23):7162-70. Takeuchi C, Galvé R, Nieva J, Witter DP, Wentworth AD, Troseth RP, Lerner RA, Wentworth P. PMID: 16752907.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    87. Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization. Nat Chem Biol. 2006 May; 2(5):249-53. Bosco DA, Fowler DM, Zhang Q, Nieva J, Powers ET, Wentworth P, Lerner RA, Kelly JW. PMID: 16565714.
      View in: PubMed   Mentions: 141     Fields:    Translation:HumansCells
    88. High speed detection of circulating tumor cells. Biosens Bioelectron. 2006 Apr 15; 21(10):1893-9. Hsieh HB, Marrinucci D, Bethel K, Curry DN, Humphrey M, Krivacic RT, Kroener J, Kroener L, Ladanyi A, Lazarus N, Kuhn P, Bruce RH, Nieva J. PMID: 16464570.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCells
    89. Immunoglobulins can utilize riboflavin (Vitamin B2) to activate the antibody-catalyzed water oxidation pathway. Immunol Lett. 2006 Feb 28; 103(1):33-8. Nieva J, Kerwin L, Wentworth AD, Lerner RA, Wentworth P. PMID: 16386801.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    90. SHP1 expression in bone marrow biopsies of myelodysplastic syndrome patients: a new prognostic factor. Br J Haematol. 2005 Jun; 129(6):791-4. Mena-Duran AV, Togo SH, Bazhenova L, Cervera J, Bethel K, Senent ML, Nieva J, Sanz GF, Sanz MA, Saven A, Mustelin T. PMID: 15953006.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    91. The antibody-catalyzed water oxidation pathway--a new chemical arm to immune defense? Trends Biochem Sci. 2004 May; 29(5):274-8. Nieva J, Wentworth P. PMID: 15130564.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    92. Metabolite-initiated protein misfolding may trigger Alzheimer's disease. Proc Natl Acad Sci U S A. 2004 Apr 06; 101(14):4752-7. Zhang Q, Powers ET, Nieva J, Huff ME, Dendle MA, Bieschke J, Glabe CG, Eschenmoser A, Wentworth P, Lerner RA, Kelly JW. PMID: 15034169; PMCID: PMC387320.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCells
    93. Cladribine activity in systemic mast cell disease: application of biochemistry in the modern era of molecular biology. Leuk Res. 2004 Feb; 28(2):113-4. Nieva J, Saven A. PMID: 14654073.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    94. Evidence for ozone formation in human atherosclerotic arteries. Science. 2003 Nov 07; 302(5647):1053-6. Wentworth P, Nieva J, Takeuchi C, Galve R, Wentworth AD, Dilley RB, DeLaria GA, Saven A, Babior BM, Janda KD, Eschenmoser A, Lerner RA. PMID: 14605372.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    95. Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia. Blood. 2003 Aug 01; 102(3):810-3. Nieva J, Bethel K, Saven A. PMID: 12663446.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCellsCTClinical Trials
    96. Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science. 2002 Dec 13; 298(5601):2195-9. Wentworth P, McDunn JE, Wentworth AD, Takeuchi C, Nieva J, Jones T, Bautista C, Ruedi JM, Gutierrez A, Janda KD, Babior BM, Eschenmoser A, Lerner RA. PMID: 12434011.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansAnimalsCells
    97. Injuries in youth ice hockey: a pilot surveillance strategy. Mayo Clin Proc. 1995 Apr; 70(4):350-6. Stuart MJ, Smith AM, Nieva JJ, Rock MG. PMID: 7898141.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    Jorge's Networks
    Concepts (395)
    Derived automatically from this person's publications.
    Co-Authors (50)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department